January 10, 2025 Royalty Pharma simplifies corporate structure with $1.1 bln deal Royalty Pharma said on Friday it would pay about $1.1 billion to acquire RP Management, an organization that ...
Citi views the recent volatility in shares of Royalty Pharma (RPRX) as a buying opportunity. Worries over the tariff impact to biopharma have ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback